Could a nerve block boost frozen shoulder treatment?
NCT ID NCT07680504
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study compares two treatments for frozen shoulder (retractile capsulitis): a standard steroid injection into the shoulder joint versus that same injection plus a nerve block near the shoulder blade. The nerve block uses a numbing medicine and a steroid to calm the nerve that supplies the shoulder. Researchers want to see if the combination improves shoulder function more than the injection alone over three months. About 38 adults with shoulder pain and stiffness lasting 2 to 12 months will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
betamethasone (Diprostene) and lidocaine
What this could lead to
If it works, this combination approach could offer better pain relief and faster recovery for people with frozen shoulder.
What could go wrong
This is a small, early-phase pilot study, so results may not apply to everyone. The nerve block itself carries rare risks like bleeding or nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETRACTILE CAPSULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nantes
Nantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••